Table 1. Patient characteristics features of patient cohorts in relation to EGFR and ALK status.
| EGFR mutation | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Malignancy pleural effusion (n = 144) | Formalin-fixed paraffin-embedded (n = 190) | Malignancy pleural effusion (n = 47) | Formalin-fixed paraffin-embedded (n = 89) | ||||||||||||||||||||
| Positive (n = 97) | Negative (n = 47) | p | Positive (n = 101) | Negative (n = 89) | p | Positive (n = 5) | Negative (n = 42) | p | Positive (n = 9) | Negative (n = 80) | p | ||||||||||||
| Age | |||||||||||||||||||||||
| Mean | 69.3 | 70.1 | NS | 67.1 | 62.3 | NS | 56.4 | 69 | <0.001 | 55.8 | 68.5 | <0.001 | |||||||||||
| Range | 35–100 | 31–92 | 41–92 | 40–90 | 38–68 | 31–92 | 38–76 | 42–90 | |||||||||||||||
| Gender | |||||||||||||||||||||||
| Male | 43 (29.9%) | 29 (20.1%) | NS | 48 (25.3%) | 57 (30.0%) | NS | 2 (4.3%) | 27 (57.4%) | NS | 4 (4.5%) | 44 (49.4%) | NS | |||||||||||
| Female | 54 (37.5%) | 18 (12.5%) | 53 (27.9%) | 32 (16.8%) | 3 (6.4%) | 15 (31.9%) | 5 (5.6%) | 36 (40.4%) | |||||||||||||||
NS: Not Significant.
Bold fonts indicate significant p values.